The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
2 reports and counting
Updated daily with latest market intelligence
Fundraising
Lyell Immunopharma
Lyell Immunopharma Raises $425M in Series C
Lyell Immunopharma, a Biotech company based in 201 Haskins Way, South San Francisco, CA 94080, has raised $425M in Series C at a $1.4B valuation led by GV, F-Prime Capital, Bain Capital Life Sciences, Patient Square Capital, Bristol Myers Squibb.
Fundraising News Team
Mar 9, 2024
2 min read
Biotech
Lyell Immunopharma
Lyell Immunopharma raises $425M Series C at $1.4B valuation
Lyell Immunopharma raises $425M in Series C at $1.4B valuation. T-cell reprogramming for solid tumors...
Editorial Team
Mar 9, 2024
1 min read•$425M
Page 1
Showing 2 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.